CVE-2023-40280 :: Enginsight Vulnerability Database

Provider	Type	Base Score	Atk. Vector	Atk. Complexity	Priv. Required	Vector
NIST	NIST	7.5 HIGH	NETWORK	LOW	NONE	CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
mitre	CNA	---				---
CISA-ADP	ADP	7.5 HIGH	NETWORK	LOW	NONE	CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
CVE	ADP	---				---

Base Score

CVSS 3.x

EPSS Score

Percentile: 78%

Vendor	Product	Version
openclinic_ga_project	openclinic_ga	5.247.01

𝑥

= Vulnerable software versions

Known Exploits!

Common Weakness Enumeration

CWE-22 - Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
The software uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the software does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.

References

https://github.com/BugBountyHunterCVE/CVE-2023-40280/blob/main/CVE-2023-40280_Authenticated-Directory-Path-Traversal_OpenClinic-GA_5.247.01_Report.md

https://sourceforge.net/projects/open-clinic/

https://github.com/BugBountyHunterCVE/CVE-2023-40280/blob/main/CVE-2023-40280_Authenticated-Directory-Path-Traversal_OpenClinic-GA_5.247.01_Report.md

https://sourceforge.net/projects/open-clinic/